Change in Aiforia Technologies Plc’s Management Team

Aiforia Technologies Plc, Company release, May 8, 2025 at 3:00 p.m. EEST

Tuomas Ropponen, Chief Technology Officer of Aiforia Technologies Plc and a member of the Management Team, has announced that he is leaving his position with Aiforia to pursue new challenges outside the company. Ropponen will continue to work for Aiforia as an employee until May 25, 2025 and will continue to serve as a technology advisor to the company after that.

Tuomas Ropponen has worked for Aiforia since 2016, and he has been the company’s Chief Technology Officer and a member of the Management Team since 2017.

“On behalf of Aiforia, I would like to warmly thank Tuomas for his significant contribution to the company. Over the past nine years, Tuomas has demonstrated exceptional commitment and vision in building a world-class AI technology and software development team for Aiforia. Thanks to this team of top talent, we have been able to develop the market-leading AI-based image analysis platform that meets the demanding needs of the pathology field. I wish Tuomas the best of luck and success, and I am very pleased that our cooperation will continue in the future as well,” says Jukka Tapaninen, CEO of Aiforia.

Aiforia has launched a search for Ropponen’s successor and will release a separate announcement regarding the appointment. During the transition period, the position will be held by the company’s Chief Product Officer and member of the Management Team, Panu Kauppila. Panu has been with the company since 2022 and has more than 25 years of experience in productizing innovations in the medical technology sector and leading product development in international companies.

Further inquiries
Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/

Certified Adviser 
UB Corporate Finance Ltd
ubcf@unitedbankers.fi

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com